Ocular surface disease
Treating ocular surface disease: new agents in development
8
Therapeutic uses of scleral contact lenses for ocular surface disease: patient selection and special considerations
10
<p>Impact of Ocular Surface Disease Treatment in Patients with Glaucoma</p>
9
Prevalence of ocular surface disease symptoms and risk factors in group of university students in Monterrey, Mexico
7
The use of autologous serum for the treatment of ocular surface disease at a Swedish tertiary referral center
8
The Anatomical Dry Eye —A Different Form of Ocular Surface Disease Deserves Focus
7
Challenges in the clinical measurement of ocular surface disease in glaucoma patients
9
A multicenter evaluation of ocular surface disease prevalence in patients with glaucoma
6
<p>Influence of bacterial burden on meibomian gland dysfunction and ocular surface disease</p>
10
Diagnostic Evaluation of Ocular Surface Disease Index Questionnaire for Dry Eye Diseases
5
Symptoms and signs of ocular surface disease related to topical medication in patients with glaucoma
7
Ocular surface disease in patients with glaucoma or ocular hypertension treated with either BAK-preserved latanoprost or BAK-free travoprost
9
Ocular surface disease in posttrabeculectomy/mitomycin C patients
5
Effects of preservative-free tafluprost on tear film osmolarity, tolerability, and intraocular pressure in previously treated patients with open-angle glaucoma
7
SIDRE: Symptomatic Improvement of Dry Eye Study
6
Corneal permeability changes in dry eye disease: an observational study
6
Assessment of tear-evaporation rate in thyroid-gland patients
5
The course of dry eye after phacoemulsification surgery
5
Case Control study for Ocular surface risk factors in Microbial Keratitis
123
Dry eye disease after refractive surgery
5